AAAAAA

   
Results: 1-14 |
Results: 14
EFFECT OF FLUCONAZOLE ON THE STEADY-STATE PHARMACOKINETICS OF DELAVIRDINE IN HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE PATIENTS
Authors: BORIN MT COX SR HERMAN BD CAREL BJ ANDERSON RD FREIMUTH WW
Citation: Mt. Borin et al., EFFECT OF FLUCONAZOLE ON THE STEADY-STATE PHARMACOKINETICS OF DELAVIRDINE IN HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE PATIENTS, Antimicrobial agents and chemotherapy, 41(9), 1997, pp. 1892-1897
SINGLE-DOSE PHARMACOKINETICS OF DELAVIRDINE MESYLATE AND DIDANOSINE IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: MORSE GD FISCHL MA SHELTON MJ COX SR DRIVER M DEREMER M FREIMUTH WW
Citation: Gd. Morse et al., SINGLE-DOSE PHARMACOKINETICS OF DELAVIRDINE MESYLATE AND DIDANOSINE IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Antimicrobial agents and chemotherapy, 41(1), 1997, pp. 169-174
STEADY-STATE PHARMACOKINETICS OF DELAVIRDINE IN HIV-POSITIVE PATIENTS- EFFECT ON ERYTHROMYCIN BREATH TEST
Authors: CHENG CL SMITH DE CARVER PL COX SR WATKINS PB BLAKE DS KAUFFMAN CA MEYER KM AMIDON GL STETSON PL
Citation: Cl. Cheng et al., STEADY-STATE PHARMACOKINETICS OF DELAVIRDINE IN HIV-POSITIVE PATIENTS- EFFECT ON ERYTHROMYCIN BREATH TEST, Clinical pharmacology and therapeutics, 61(5), 1997, pp. 531-543
IMMEDIATE VERSUS DEFERRED TREATMENT FOR ADVANCED PROSTATIC-CANCER - INITIAL RESULTS OF THE MEDICAL-RESEARCH-COUNCIL TRIAL
Authors: ADIB RS ANDERSON JB ASHKEN MH BAUMBER CD BEVIS CRA BEYNON LL BLAXLAND JW BOAG V BOLGER JJ BOREHAM J BRAMBLE FJ BREAKEY J BULLOCK KN BURRETT J CARSWELL GF CHARLTON CAC CHILTON CP CHISHOLM GD CLACK R CLARIDGE M CLARK PB COULTON ER COX SR CRESSWELL SM CROWTHER J DAVIES M DESOUSA BA DEANE RF DEVEREUX MH DOYLE PT ENGLISH P EVANS CM FELLOWS GJ FERNIE CGM FORDHAM M FRENCH ME GACHES CGC GALLEGOS CRR GILLILAND EL GLAHOLM J GLASHAN RW GRANT JBP GRAYSON CEA GREEN NA GRIFFIN S HALL RR HAFNER B HARGREAVE TB HARRISON GSM HEAL MR HEHIR M HETHERINGTON J JAMES MJ JONES PA JONES RA JURCZYK LN KIRK D KNIGHT S LAWRENCE WT LOGIE JRC LUCAS M LUCK RJ MCGREGOR A MCKELVIE GB MOFFAT LEF MOORE KTH MORGAN RJ NEWLING DWK ORR PGG PARISH S PERRY K PETO R POLLARD R POWELL CS RADLEY A RAMPLING R RENNIE CD RHIND JR RICHARDS B ROBERTS C ROBINSON MRG ROGERS ACN ROSE MB ROSS RTA ROYLE MG SAGAR S SETHIA KK SHEARER RJ SHEPHEARD BGF SMITH J SMITH JC SMITH MF SMITH PH SOLE GM STEPHENSON TP STEWART AL STOWER MJ STYLES RA THOMSON RW THOMPSON E TOLLEY DA TOWNELL NH TURNER DTL URWIN GH WARD JP WATSON GS WATSON GM WIGHTMAN JAK WILLIAMS JL
Citation: Rs. Adib et al., IMMEDIATE VERSUS DEFERRED TREATMENT FOR ADVANCED PROSTATIC-CANCER - INITIAL RESULTS OF THE MEDICAL-RESEARCH-COUNCIL TRIAL, British Journal of Urology, 79(2), 1997, pp. 235-246
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA WITH NEONATAL DEATH DUE TO RESPIRATORY-FAILURE - MOLECULAR CONFIRMATION FOR SUBSEQUENT PRENATAL-DIAGNOSIS
Authors: GREBE TA COX SR BOGLE A KINNEARNY M KORKKO J
Citation: Ta. Grebe et al., SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA WITH NEONATAL DEATH DUE TO RESPIRATORY-FAILURE - MOLECULAR CONFIRMATION FOR SUBSEQUENT PRENATAL-DIAGNOSIS, American journal of human genetics, 61(4), 1997, pp. 555-555
RANDOMIZED, CONTROLLED PHASE I II TRIAL OF COMBINATION THERAPY WITH DELAVIRDINE (U-90152S) AND CONVENTIONAL NUCLEOSIDES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PATIENTS/
Authors: DAVEY RT CHAITT DG REED GF FREIMUTH WW HERPIN BR METCALF JA EASTMAN PS FALLOON J KOVACS JA POLIS MA WALKER RE MASUR H BOYLE J COLEMAN S COX SR WATHEN L DAENZER CL LANE HC
Citation: Rt. Davey et al., RANDOMIZED, CONTROLLED PHASE I II TRIAL OF COMBINATION THERAPY WITH DELAVIRDINE (U-90152S) AND CONVENTIONAL NUCLEOSIDES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PATIENTS/, Antimicrobial agents and chemotherapy, 40(7), 1996, pp. 1657-1664
GASTRIC ACIDIFICATION INCREASES DELAVIRDINE (DLV) MESYLATE EXPOSURE IN HIV+ SUBJECTS WITH GASTRIC HYPOACIDITY (GH)
Authors: MORSE GD ADAMS JM SHELTON MJ HEWITT RG COX SR CHAMBERS JH
Citation: Gd. Morse et al., GASTRIC ACIDIFICATION INCREASES DELAVIRDINE (DLV) MESYLATE EXPOSURE IN HIV+ SUBJECTS WITH GASTRIC HYPOACIDITY (GH), Clinical pharmacology and therapeutics, 59(2), 1996, pp. 47-47
SAFETY, TOLERANCE, AND PHARMACOKINETICS OF ATEVIRDINE MESYLATE (U-87201E) IN ASYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS
Authors: BEENTIKTAK AMM VREHEN HM SCHNEIDER MME VANDERFELTZ M BRANGER T WARD P COX SR HARRY JD BORLEFFS JCC
Citation: Amm. Beentiktak et al., SAFETY, TOLERANCE, AND PHARMACOKINETICS OF ATEVIRDINE MESYLATE (U-87201E) IN ASYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS, Antimicrobial agents and chemotherapy, 39(3), 1995, pp. 602-607
SINGLE-DOSE RESPONSE AND MULTIPLE-DOSE-RESPONSE RELATIONSHIPS OF BETA-CAROTENE IN CYSTIC-FIBROSIS
Authors: HOMNICK DN SPILLERS CR COX SR COX JH YELTON LA DELOOF MJ OLIVER LK RINGER TV
Citation: Dn. Homnick et al., SINGLE-DOSE RESPONSE AND MULTIPLE-DOSE-RESPONSE RELATIONSHIPS OF BETA-CAROTENE IN CYSTIC-FIBROSIS, The Journal of pediatrics, 127(3), 1995, pp. 491-494
HYPOXIA REGULATES VASCULAR ENDOTHELIAL GROWTH-FACTOR GENE-EXPRESSION IN ENDOTHELIAL-CELLS - IDENTIFICATION OF A 5'-ENHANCER
Authors: LIU YX COX SR MORITA T KOUREMBANAS S
Citation: Yx. Liu et al., HYPOXIA REGULATES VASCULAR ENDOTHELIAL GROWTH-FACTOR GENE-EXPRESSION IN ENDOTHELIAL-CELLS - IDENTIFICATION OF A 5'-ENHANCER, Circulation research, 77(3), 1995, pp. 638-643
THE EFFECT OF COMPETITIVE AND NONLINEAR PLASMA-PROTEIN BINDING ON THESTEREOSELECTIVE DISPOSITION AND METABOLIC INVERSION OF IBUPROFEN IN HEALTHY-SUBJECTS
Authors: SMITH DE PALIWAL JK COX SR BERARDI RR DUNNKUCHARSKI VA ELTA GH
Citation: De. Smith et al., THE EFFECT OF COMPETITIVE AND NONLINEAR PLASMA-PROTEIN BINDING ON THESTEREOSELECTIVE DISPOSITION AND METABOLIC INVERSION OF IBUPROFEN IN HEALTHY-SUBJECTS, Biopharmaceutics & drug disposition, 15(7), 1994, pp. 545-561
USE OF RECOMBINANT SOLUBLE CD4 PSEUDOMONAS EXOTOXIN, A NOVEL IMMUNOTOXIN, FOR TREATMENT OF PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: DAVEY RT BOENNING CM HERPIN BR BATTS DH METCALF JA WATHEN L COX SR POLIS MA KOVACS JA FALLOON J WALKER RE SALZMAN N MASUR H LANE HC
Citation: Rt. Davey et al., USE OF RECOMBINANT SOLUBLE CD4 PSEUDOMONAS EXOTOXIN, A NOVEL IMMUNOTOXIN, FOR TREATMENT OF PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, The Journal of infectious diseases, 170(5), 1994, pp. 1180-1188
CONSIDERATIONS FOR PHASE-1 CONCENTRATION CONTROLLED TRIALS (CCT) IN HIV-INFECTED PATIENTS - ATEVIRDINE (ATV) AS AN EXAMPLE
Authors: COX SR REICHMAN RC KNUTH D
Citation: Sr. Cox et al., CONSIDERATIONS FOR PHASE-1 CONCENTRATION CONTROLLED TRIALS (CCT) IN HIV-INFECTED PATIENTS - ATEVIRDINE (ATV) AS AN EXAMPLE, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 157-157
STEREOSELECTIVE, COMPETITIVE, AND NONLINEAR PLASMA-PROTEIN BINDING OFIBUPROFEN ENANTIOMERS AS DETERMINED IN-VIVO IN HEALTHY-SUBJECTS
Authors: PALIWAL JK SMITH DE COX SR BERARDI RR DUNNKUCHARSKI VA ELTA GH
Citation: Jk. Paliwal et al., STEREOSELECTIVE, COMPETITIVE, AND NONLINEAR PLASMA-PROTEIN BINDING OFIBUPROFEN ENANTIOMERS AS DETERMINED IN-VIVO IN HEALTHY-SUBJECTS, Journal of pharmacokinetics and biopharmaceutics, 21(2), 1993, pp. 145-161
Risultati: 1-14 |